BeOne Medicines Ltd. (ONC)
Pharmaceutical Preparations
Latest Price
$316.01
TTM P/E
929.44
Normalized P/E
--
Div Yield
--
Book Value
3.30
P/B Ratio
95.75
Valuation metrics
adjust assumptions →EPS: $0.19
Book value / share: $3.03
Formula: √(22.5 × EPS × BVPS)
Graham Number
$3.60
99% downside
EPS: $0.19
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$2.85
99% downside
Institutional Ownership
2.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 8.80M | $2.61B | 0.61% | -- | 2026-03-31 |
| PRIMECAP MANAGEMENT CO/CA/ | 4.98M | $1.48B | 0.34% | -5.4K | 2026-03-31 |
| Capital International Investors | 4.16M | $1.23B | 0.29% | -955.1K | 2026-03-31 |
| FMR LLC | 3.69M | $1.10B | 0.26% | -299.0K | 2026-03-31 |
| Capital World Investors | 1.62M | $481.0M | 0.11% | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 1.05M | $312.0M | 0.07% | +495.0K | 2026-03-31 |
| HHLR ADVISORS, LTD. | 1.03M | $307.0M | 0.07% | -- | 2026-03-31 |
| Temasek Holdings (Private) Ltd | 862.6K | $256.0M | 0.06% | -56.9K | 2026-03-31 |
| BlackRock, Inc. | 657.5K | $195.0M | 0.05% | -18.7K | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 539.8K | $160.0M | 0.04% | -832.9K | 2026-03-31 |